XML 31 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)
$ in Millions
Total
Total Baxter stockholders' equity
Common stock
Common stock in treasury
Additional contributed capital
Retained earnings
Accumulated other comprehensive income (loss)
Noncontrolling interests
Balance, beginning of period (in shares) at Dec. 31, 2020     683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2020 $ 8,726 $ 8,689 $ 683 $ (11,051) $ 6,043 $ 16,328 $ (3,314) $ 37
Balance, beginning of period, treasury (in shares) at Dec. 31, 2020       179,000,000        
Gains (losses)                
Net income 300 298       298   2
Other comprehensive income (loss) (166) (166)         (166)  
Purchases of treasury stock (in shares)       4,000,000        
Purchases of treasury stock (300) (300)   $ (300) 0      
Stock issued under employee benefit plans and other (in shares)       (2,000,000)        
Stock issued under employee benefit plans and other 55 55   $ 55 0      
Dividends declared on common stock (124) (124)       (124)    
Change in noncontrolling interests (1)             (1)
Balance, end of period (in shares) at Mar. 31, 2021     683,000,000          
Balance, end of period (in usd) at Mar. 31, 2021 $ 8,490 8,452 $ 683 $ (11,296) 6,043 16,502 (3,480) 38
Balance, end of period, treasury (in shares) at Mar. 31, 2021       181,000,000        
Balance, beginning of period (in shares) at Dec. 31, 2021 683,494,944   683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2021 $ 9,121 9,077 $ 683 $ (11,488) 6,197 17,065 (3,380) 44
Balance, beginning of period, treasury (in shares) at Dec. 31, 2021 181,879,516     182,000,000        
Gains (losses)                
Net income $ 73 71       71   2
Other comprehensive income (loss) $ (7) (7)         (7)  
Purchases of treasury stock (in shares) 3,600,000              
Stock issued under employee benefit plans and other (in shares)       (2,000,000)        
Stock issued under employee benefit plans and other $ 76 76   $ 66 10      
Dividends declared on common stock (142) (142)       (142)    
Change in noncontrolling interests $ (2)             (2)
Balance, end of period (in shares) at Mar. 31, 2022 683,494,944   683,000,000          
Balance, end of period (in usd) at Mar. 31, 2022 $ 9,119 $ 9,075 $ 683 $ (11,422) $ 6,207 $ 16,994 $ (3,387) $ 44
Balance, end of period, treasury (in shares) at Mar. 31, 2022 180,058,105     180,000,000